...
首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Prevalence of qnr, intI, and intII genes in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from clinical samples in Iran
【24h】

Prevalence of qnr, intI, and intII genes in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from clinical samples in Iran

机译:从伊朗临床样品中分离出的产生广谱β-内酰胺酶(ESBL)的大肠杆菌中qnr,intI和intII基因的普遍性

获取原文
           

摘要

Purpose: To investigate the prevalence of qnr, intI, and intII genes in extended spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from clinical samples in Kerman, Iran. Methods: A total of 127 E. coli were collected from clinical samples in Kerman hospitals. The antibiotic susceptibility test was performed using disc diffusion method, while the presence of ESBL-producing E. coli was determined by phenotypic confirmatory test. Furthermore, the presence of qnrA, qnrB, qnrS, intI, intII, and β-lactamase-encoding genes was detected by polymerase chain reaction (PCR). Finally, the data were analyzed and associations between different genes and antibiotic resistance were evaluated. Results: The highest and lowest rates of resistance were observed against ampicillin (72.4 %) and imipenem (2.3 %), respectively. Also, 41.7 % of the isolates produced ESBL-enzymes. The qnrS and genes were detected in 6.3 and 0.78 %, respectively, of the isolates, while qnrA gene was not detected in the current study. The results revealed that 64.5 and 10.2 % of isolates carried intI and intII genes, respectively. Data analysis showed a significant association between ESBL production and class I integrin gene in E. coli isolates. Conclusion: Due to the variation in the resistance patterns of E. coli against antibiotics in different geographical regions, antimicrobial treatments should be based on local experience. Also, the coexistence of ESBL and intI gene in the majority of E. coli isolates suggests that care should be taken in choosing antibiotic therapy.
机译:目的:研究从伊朗克尔曼市的临床样本中分离出的产生超广谱β-内酰胺酶(ESBL)的大肠杆菌中qnr,intI和intII基因的患病率。方法:从克尔曼医院的临床样本中共收集到127株大肠杆菌。使用盘扩散法进行抗生素敏感性试验,而通过表型确认试验确定产生ESBL的大肠杆菌的存在。此外,通过聚合酶链反应(PCR)检测到qnrA,qnrB,qnrS,intI,intII和β-内酰胺酶编码基因的存在。最后,分析数据并评估不同基因与抗生素耐药性之间的关联。结果:分别观察到对氨苄西林(72.4%)和亚胺培南(2.3%)的最高和最低耐药率。同样,有41.7%的分离物产生ESBL酶。在分离株中检出qnrS和基因的比例分别为6.3%和0.78%,而在当前研究中未检出qnrA基因。结果显示,分别有64.5%和10.2%的分离株携带intI和intII基因。数据分析表明,ESBL产生与大肠杆菌分离物中的I类整联蛋白基因之间存在显着关联。结论:由于大肠杆菌在不同地理区域对抗生素的耐药性模式有所不同,因此应根据当地经验进行抗菌治疗。而且,大多数大肠杆菌分离株中ESBL和intI基因的共存表明在选择抗生素治疗时应格外小心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号